Editas Medicine Inc EDIT:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 11/26/21 EST
32.50quote price arrow up+0.13 (+0.40%)
Volume
3,335
Close
32.37quote price arrow down-0.93 (-2.79%)
Volume
776,250
52 week range
29.35 - 99.95
Loading...
  • Open32.50
  • Day High33.59
  • Day Low31.92
  • Prev Close33.30
  • 52 Week High99.95
  • 52 Week High Date01/08/21
  • 52 Week Low29.35
  • 52 Week Low Date05/11/21

Key Stats

  • Market Cap2.21B
  • Shares Out68.26M
  • 10 Day Average Volume0.93M
  • Dividend-
  • Dividend Yield-
  • Beta2.08
  • YTD % Change-53.83

KEY STATS

  • Open32.50
  • Day High33.59
  • Day Low31.92
  • Prev Close33.30
  • 52 Week High99.95
  • 52 Week High Date01/08/21
  • 52 Week Low29.35
  • 52 Week Low Date05/11/21
  • Market Cap2.21B
  • Shares Out68.26M
  • 10 Day Average Volume0.93M
  • Dividend-
  • Dividend Yield-
  • Beta2.08
  • YTD % Change-53.83

RATIOS/PROFITABILITY

  • EPS (TTM)-3.25
  • P/E (TTM)-9.96
  • Fwd P/E (NTM)-9.57
  • EBITDA (TTM)-164.525M
  • ROE (TTM)-32.05%
  • Revenue (TTM)81.14M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-205.41%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date02/23/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Editas Medicine Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Editas Medicine, Inc. is a clinical-stage gene editing company. The Company is focused on developing transformative gene-editing medicines to treat a range of serious diseases. It operates through the developing and commercializing genome editing technology segment. It is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme...
James Mullen
Chairman
Michelle Robertson
Chief Financial Officer
Bruce Eaton Ph.D.
Executive Vice President
Mark Shearman Ph.D.
Executive Vice President
Lisa Michaels M.D.
Executive Vice President
Address
11 Hurley St
Cambridge, MA
02141-2110
United States

Top Peers

SYMBOLLASTCHG%CHG
RVMD
Revolution Medicines Inc
27.02-1.85-6.41%
IBRX
Immunitybio Inc
6.50+0.15+2.36%
ALLO
Allogene Therapeutics Inc
17.98-0.69-3.70%
CCXI
ChemoCentryx Inc
36.28-2.60-6.69%
SAVA
Cassava Sciences Inc
55.96-2.09-3.60%